We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Itaú Unibanco
ITUB
$91.6B
| $14.7M | 0.01% |
1,802,380
+1,623,025
| +905% | +$13.5M |
|
852
Maximus
MMS
$2.95B
| $14.7M | 0.01% |
273,805
+216,284
| +376% | +$13.5M |
|
853
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.97B
| $14.7M | 0.01% |
122,966
-10,150
| -8% | -$1.14M |
|
854
Cleveland-Cliffs
CLF
$7.01B
| $14.6M | 0.01% |
1,553,631
+698,594
| +82% | +$7.68M |
|
855
Vale
VALE
$66.2B
| $14.5M | 0.01% |
964,261
+437,959
| +83% | +$7.13M |
|
856
Generac Holdings
GNRC
$11.2B
| $14.5M | 0.01% |
49,381
-37,511
| -43% | -$9.4M |
|
857
OneMain Financial
OMF
$7.28B
| $14.4M | 0.01% |
236,777
+169,772
| +253% | +$9.56M |
|
858
Adtran
ADTN
$618M
| $14.4M | 0.01% |
1,038,292
+146,772
| +16% | +$2.29M |
|
859
G-III Apparel Group
GIII
$1.17B
| $14.4M | 0.01% |
427,583
+264,724
| +163% | +$8.35M |
|
860
Rigel Pharmaceuticals
RIGL
$885M
| $14.4M | 0.01% |
367,393
-230,985
| -39% | -$7.12M |
|
861
Structure Therapeutics
GPCR
$2.88B
| $14.4M | 0.01% |
267,592
+198,485
| +287% | +$8.78M |
|
862
Regeneron Pharmaceuticals
REGN
$83.4B
| $14.3M | 0.01% |
23,000
+22,647
| +6,416% | +$15.4M |
|
|
JBTM
863
JBT Marel
JBTM
$6.02B
| $14.3M | 0.01% |
98,874
-64,381
| -39% | -$8.34M |
|
864
CRH
CRH
$60.3B
| $14.3M | 0.01% |
133,817
-10,374
| -7% | -$1.14M |
|
865
Medtronic
MDT
$118B
| $14.3M | 0.01% |
+182,300
| New | +$14.7M |
|
866
Richtech Robotics
RR
$392M
| $14.2M | 0.01% |
6,746,011
+3,935,598
| +140% | +$9.56M |
|
867
Sociedad Química y Minera de Chile
SQM
$21.6B
| $14.2M | 0.01% |
192,246
-112,864
| -37% | -$9.45M |
|
868
Kilroy Realty
KRC
$4.2B
| $14.2M | 0.01% |
+378,971
| New | +$12.9M |
|
869
Denali Therapeutics
DNLI
$3.53B
| $14.1M | 0.01% |
549,830
-441,438
| -45% | -$9.07M |
|
870
Microchip Technology
MCHP
$39.8B
| $14.1M | 0.01% |
154,729
+121,930
| +372% | +$10.9M |
|
871
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$13.9B
| $14.1M | 0.01% |
155,600
-1,452,600
| -90% | -$129M |
|
872
Varonis Systems
VRNS
$5.22B
| $14.1M | 0.01% |
335,736
+115,784
| +53% | +$3.39M |
|
873
JetBlue
JBLU
$1.71B
| $14.1M | 0.01% |
2,455,301
-1,217,358
| -33% | -$6.2M |
|
874
CALL
First Solar
FSLR
$22.9B
| $14M | 0.01% |
59,500
-97,400
| -62% | -$22.8M |
|
875
uniQure
QURE
$3.17B
| $14M | 0.01% |
304,702
+181,966
| +148% | +$4.76M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.